ALLMedicine™ Heart Failure Center

Mar 28th, 2023 - Evaluation of longitudinal strain (LS) from two-dimensional echocardiography is useful for global and regional left ventricular (LV) dysfunction assessment. We determined whether the LS reflects contraction process in patients with asynchronous LV...

Mar 28th, 2023 - To describe incidence of cardiotoxicity in patients anthracycline exposure who subsequently receive EPOCH for non-Hodgkin lymphoma (NHL). We conducted a retrospective cohort study of adults with anthracycline exposure who subsequently received EPO...

Mar 28th, 2023 - Sacubitril/valsartan is a new cardiovascular agent characterized by its dual inhibition on the reninangiotensin system (RAS) and the neprilysin. As neprilysin also involved itself in the degradation of amyloid-β, there is an ongoing concern about ...

Mar 28th, 2023 - In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and autho...

Mar 28th, 2023 - The aim of our study is to assess the ability of left atrial (LA) strain values to improve left ventricular and diastolic pressure (LVEDP) non-invasive estimation as compared with traditional echocardiographic indexes in the acute phase of Takotsu...

Mar 24th, 2023 - Heart failure with preserved ejection fraction (HFpEF) is one of the most common forms of heart failure; its prevalence is increasing, and outcomes are worsening. Affected patients often experience severe exertional dyspnea and debilitating fatigu...

Mar 2nd, 2023 - DALLAS, March 2, 2023 — A new study found that walking an additional 500 steps, or about one-quarter of a mile, per day was associated with a 14% lower risk of heart disease, stroke or heart failure, according to preliminary research to be present...

Feb 23rd, 2023 - The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support.|2023|Bernhardt AM,Copeland H,Deswal A,Gluck J,Givertz MM,|

Feb 9th, 2023 - The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support.|2023|Bernhardt AM,Copeland H,Deswal A,Gluck J,Givertz MM,|surgery,

Oct 7th, 2022 - People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent clinical trials support new approaches to treat diabetes and CKD. The...

Mar 24th, 2023 - The overall study objectives are: To determine the longitudinal relationships between circulating markers, such as Neuregulin (NRG)-1Beta levels and incident risk of adverse cardiovascular outcomes in patients exposed to anthracycline, trastuzumab...

Mar 23rd, 2023 - ANTHEM-HFrEF is a multi-center, open-label, randomized controlled clinical trial with an adaptive design. Patients with symptomatic heart failure and reduced LVEF will be enrolled and randomized 2:1 to receive VITARIA system implantation on the ri...

Mar 23rd, 2023 - Introduction: Aortic regurgitation (AR) is the third most frequent valvular heart disease in Western countries affecting rather young patients, mostly men. The degenerative process on the trileaflet aortic valve is the main cause of AR, followed b...

Mar 22nd, 2023 - Adult (>18 years old), advanced heart failure NYHA Class III with dyspnea upon mild physical activity or Class IV patients who are refractory to advanced heart failure management and meet study Inclusion/Exclusion criteria will be enrolled. The ob...

Mar 22nd, 2023 - The purpose of this study is to evaluate the effect of finerenone compared to placebo (a tablet without active substance) in the reduction of cardiovascular death (generally meaning death due to disease of the heart or blood vessels) and total Hea...

Approximately 90% of Americans eat too much sodium. This practice leads to increased blood pressure, which increases the risk for stroke, coronary heart disease, heart failure, and renal disease. Population-based strategies to reduce sodium intake...

Mar 23rd, 2023 - NEW ORLEANS – Treatment of patients with heart failure with preserved ejection fraction (HFpEF) with the SGLT2 inhibitor dapagliflozin (Farxiga) for 24 weeks produced significant and beneficial reductions in left-heart filling pressures in a mecha.

Mar 21st, 2023 - For the heart failure population, BMI obesity no longer appeared to hold counterintuitive protective effects after comprehensive adjustment for natriuretic peptides and other prognostic variables in a post hoc analysis of PARADIGM. Eliminating thi...

Mar 16th, 2023 - HONOLULU – In the clinical experience of Julie C. Harper, MD, an increasing number of women with acne are turning to off-label, long-term treatment with spironolactone.

Mar 15th, 2023 - Thoracic Oncology Network Interventional Procedures Section The management of recurrent pleural effusions is challenging. Indwelling tunneled pleural catheters (IPCs) have been shown to reduce the need for additional pleural procedures, admissions.